Narrow your search
UC Irvine researchers create toxin-capturing nanoparticles that successfully stop bee venom in the bloodstream of mice and could one day have implications for other toxins, too.
A new vaccination approach out of CalTech focuses on providing protective antibodies upfront, rather than designing substances that will provoke an effective immune response.
Researchers turn to physics, not just chemistry, to help break down bacterial cell membranes and fight infections.
A mosquito lands on your leg. It takes you a few minutes to notice, but in that time a lot has happened. Check out some amazing footage of mosquito probes breaking through skin and searching for blood vessels.
An MIT team has developed a paper stick that could someday be used as an inexpensive and accurate way to detect a range of cancers. It holds particular promise for the developing world.
A handheld unit designed for police and security agencies uses nanoparticles to search for indications of illicit partying.
Formed of antibodies and DNA, these molecular automata could help design better drugs to fight cancer, autoimmune diseases.
Doctors say that a toddler born with HIV shows no signs of the virus a year after being removed from antiretroviral therapy.
U.K. researchers announce approval to launch the first human clinical trial of a genetically modified anti-HIV microbicide called P2G12, grown in Germany.
As part of Road Trip 2010, CNET reporter Daniel Terdiman spends a day at General Electric's famed R&D labs and sees a glimpse of some of the technologies the industrial giant will be coming out with in the future.